An investigation was announced for investors in NASDAQ:ETRM shares concerning possible breaches of fiduciary duties by certain officers and directors at EnteroMedics Inc.
Investors who purchased shares of EnteroMedics Inc (NASDAQ:ETRM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain EnteroMedics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Saint Paul, MN based EnteroMedics Inc is a medical device company that is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.
Shares of EnteroMedics Inc (NASDAQ:ETRM) closed on March 30, 2017 at $5.79 per share.
Those who purchased NASDAQ:ETRM shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com